Consolidated Statement Of Income

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7301461

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Consolidated statement of income
Statement of income
Net sales
28,550,181,000 JPY
375,859,000 JPY
13,802,313,000 JPY
42,352,494,000 JPY
42,422,617,000 JPY
42,728,354,000 JPY
-305,736,000 JPY
23,903,955,000 JPY
12,700,344,000 JPY
37,001,503,000 JPY
36,678,404,000 JPY
-323,099,000 JPY
397,202,000 JPY
36,604,300,000 JPY
Cost of sales
11,409,066,000 JPY
9,631,957,000 JPY
Operating expenses
Selling, general and administrative expenses
24,554,334,000 JPY
21,719,007,000 JPY
Operating expenses
Operating profit (loss)
5,830,595,000 JPY
118,312,000 JPY
3,121,985,000 JPY
8,952,580,000 JPY
6,459,216,000 JPY
9,070,892,000 JPY
-2,611,676,000 JPY
5,257,968,000 JPY
2,526,140,000 JPY
7,908,202,000 JPY
5,327,439,000 JPY
-2,580,762,000 JPY
124,092,000 JPY
7,784,109,000 JPY
Net sales
Gross profit (loss)
31,013,551,000 JPY
27,046,446,000 JPY
Ordinary profit (loss)
7,949,373,000 JPY
5,495,938,000 JPY
Operating expenses
Research and development expenses
1,943,088,000 JPY
1,746,318,000 JPY
Non-operating income
Interest income
120,528,000 JPY
46,176,000 JPY
Dividend income
225,858,000 JPY
192,672,000 JPY
Other
124,229,000 JPY
77,461,000 JPY
Non-operating income
1,791,596,000 JPY
407,090,000 JPY
Extraordinary income
2,903,000 JPY
923,332,000 JPY
Cost of sales
Selling, general and administrative expenses
Extraordinary losses
200,407,000 JPY
6,336,000 JPY
Non-operating expenses
301,438,000 JPY
238,591,000 JPY
Interest expenses
232,249,000 JPY
226,110,000 JPY
Non-operating expenses
Other
69,188,000 JPY
12,481,000 JPY
Gross profit
Profit (loss) before income taxes
7,751,869,000 JPY
6,412,933,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,903,000 JPY
JPY
Gain on sale of investment securities
JPY
0 JPY
Extraordinary losses
Loss on retirement of non-current assets
3,864,000 JPY
6,336,000 JPY
Income taxes
1,625,522,000 JPY
1,005,062,000 JPY
Profit (loss)
6,126,346,000 JPY
5,407,870,000 JPY
Profit (loss) attributable to non-controlling interests
65,065,000 JPY
11,093,000 JPY
Profit (loss) attributable to owners of parent
6,061,280,000 JPY
5,396,776,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-96,198,000 JPY
1,264,461,000 JPY
Foreign currency translation adjustment
4,030,007,000 JPY
4,844,478,000 JPY
Remeasurements of defined benefit plans, net of tax
-350,742,000 JPY
-262,732,000 JPY
Other comprehensive income
3,583,067,000 JPY
5,846,207,000 JPY
Profit attributable to
Comprehensive income
9,709,413,000 JPY
11,254,078,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
9,615,870,000 JPY
11,223,314,000 JPY
Comprehensive income attributable to non-controlling interests
93,542,000 JPY
30,764,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.